Epidemiology and Therapeutic Strategies for Women With Preexisting Diabetes in Pregnancy: How Far Have We Come? The 2021 Norbert Freinkel Award Lecture
Feig D
Diabetes Care 2022;45(11):2484–2491
https://doi.org/10.2337/dci21-0027
Glycemia Reduction in Type 2 Diabetes – Glycemic Outcomes
GRADE Study Research Group; David M Nathan, John M Lachin, Ashok Balasubramanyam, et al. N Engl J Med. 2022;387(12):1063-1074
https://doi.org/10.1056/NEJMoa2200433
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis.
Milad Nazarzadeh , Zeinab Bidel, Dexter Canoy, Emma Copland, et al.
Lancet Diabetes Endocrinol. 2022 Sep;10(9):645-654.
https://doi.org/10.1016/S2213-8587(22)00172-3
Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes.
Crowther CA, Samuel D, McCowan LME, et al., for the GEMS Trial Group.
N Engl J Med 2022; 387:587-598.
https://doi.org/10.1056/NEJMoa2204091
Once-Weekly Dulaglutide for the Treatment of Youths with Type 2 Diabetes
Arslanian S, Hannon T, Philip Zeitler P, Chao L, Boucher-Berry C, Barrientos-Pérez M et al for the AWARD-PEDS Investigators
N Engl J Med 2022; 387:433-443
https://doi.org/10.1056/NEJMoa2204601
C peptide determination in the diagnosis of type one and its management: A clinical perspective
Maddaloni E, Bolli G, Randle R, Richard D, Pozzilli P, Buzzetti R et al
Diabetes Obesity and Metabolism
https://doi.org/10.1111/dom.14785
Comentarios recientes